Use of pi3kc2b inhibitors for the preservation of vascular endothelial cell barrier integrity
US-2024425863-A1 · Dec 26, 2024 · US
This page is not indexed by search engines while we improve data quality.
Ct Hospitalier Universitaire Toulouse patents in 2024
Ct Hospitalier Universitaire Toulouse was listed as an assignee on 11 patent publications in 2024.
| Metric | Value |
|---|---|
| Company | Ct Hospitalier Universitaire Toulouse |
| Year | 2024 |
| Patents | 11 |
Patents
Representative publications for Ct Hospitalier Universitaire Toulouse in 2024.
Use of PI3KC2B inhibitors for the preservation of vascular endothelial cell barrier integrity
US-12123000-B2 · Oct 22, 2024 · US
Immune cell which has an fc receptor on its surface and to which is grafted a hybrid molecule comprising an antibody fc fragment and at least one fibrin-derived citrulline peptide, and uses thereof
US-2024307538-A1 · Sep 19, 2024 · US
Methods of assessing the risk of developing progressive multifocal leukoencephalopathy in patients treated with vla-4 antagonists
US-2024301512-A1 · Sep 12, 2024 · US
Hybrid molecule comprising a fibrin-derived citrullinated peptide and an antibody or antibody fragment which binds to cd38 and/or cd138, and uses thereof
US-2024294658-A1 · Sep 5, 2024 · US
Top CPC classifications
Most common classification codes for Ct Hospitalier Universitaire Toulouse in 2024.
| CPC | Patents |
|---|---|
| A61P43/00 | 3 |
| A61K31/00 | 2 |
| A61K31/015 | 2 |
| A61K31/02 | 2 |
| A61K31/08 | 2 |
Related pages
Navigate to parent entity pages.